Pumali Gunasekera - Concepedia

Author

Pumali Gunasekera

Nottingham University Hospitals NHS Trust

Also Known As

P Gunasekera, P. Gunasekera, Pumali Gunasekera, Pumali N Gunasekera, Pumali N. Gunasekera

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Nottingham University Hospitals NHS Trust University of Bristol University of Oxford University of Nottingham King's College London

About

Pumali Gunasekera is an author at Nottingham University Hospitals NHS Trust specializing in covid-19, medicine, and covid-19 epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	974
2	Public Health	2	2	590
3	Epidemiology	2	2	590
4	Hospital Medicine	2	2	592
5	Antibiotics	1	1	555

Pumali Gunasekera

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Dominic L. Sykes, Luke Holdsworth, Pumali Gunasekera, Lung Long CovidGlobal Health CrisisCovid-19 PandemicCovid-19 EpidemiologyPublic Health	2021	553
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Dominic L. Sykes, Luke Holdsworth, Pumali Gunasekera, Long CovidMedicineGlobal Health CrisisCovid-19 PandemicClinical Epidemiology	2021	37
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31
Ventilator-associated pneumonia Pumali Gunasekera, Andrew Gratrix BJA Education	2015	30

Page 1